Abstracts

1360 – Clinical Consequences of Delaying Implementation of LA-ART for PWH With Persistent Viremia in the US

Background Long-acting (LA-) injectable cabotegravir-rilpivirine (CAB/RPV) can achieve viral suppression (VS) in PWH with poor adherence to daily ART and persistent viremia. While current DHHS guidelines recommend this indication for CAB/RPV on a case-by-case basis, the FDA is requiring a randomized trial for approval. Our objective was to project the clinical impact of delaying CAB/RPV…

1349 – Social Networks Influence PrEP Use and Preference for Long-Acting PrEP Among MSM In Baltimore

Background With advances in HIV prevention, understanding factors that promote uptake of novel PrEP agents, including social networks, could be critical to increasing coverage and interrupting HIV transmission in vulnerable populations, such as men who have sex with men (MSM). Methods We conducted a network-based online survey among MSM and transgender women (TGW) in Baltimore,…

1294 – Cost-Effectiveness of PrEP and Medications for Opioid Use Disorder in People Who Inject Drugs

Background People who inject drugs (PWID) in the US have high HIV incidence and fatal overdose rates, yet uptake is low for pre-exposure prophylaxis (PrEP; 1%) and medications for opioid use disorder (MOUD; 18%). Long-acting PrEP and MOUD formulations may improve uptake and adherence. Methods Using the validated MYRIAD multimorbidity microsimulation model (accounting for impact…

1363 – Impact of 6-Monthly ART Dispensing on Retention in Malawi: A Target Trial Emulation Study

Background Malawi implemented 6-multi-month dispensing (6MMD) of antiretroviral therapy (ART) for clinically stable clients on HIV treatment during 2019 and scaled-up implementation in 2020. We compared retention for clients who received 6MMD to those who did not receive 6MMD and assessed predictors of retention. Methods We applied a target trial emulation (TTE) approach using routine…

1302 – Depression and Suicide Risk Among Sexual and Gender Minorities: Insights From the ImPrEP CAB Brasil

Background Mental health plays an important role in the effectiveness of HIV prevention strategies, as poor mental health can lead to decreased adherence and increased vulnerability to HIV infection. Long-acting PrEP modalities can help overcome barriers related to PrEP persistence and adherence, and should be considered for those with mental health challenges. We explored the…

1298 – Trajectories of Weight Changes After GLP-1 Receptor Agonists Initiation Among Patients With HIV

Background Glucagon-like peptide-1 (GLP-1) receptor agonists (RA) have been shown to have marked efficacy in improving blood glucose and reducing weight among individuals in randomized trials. However, real-world data on weight changes after GLP-1 RA initiation among people with HIV remain limited. Methods Using patient-level data from 82 sites in the U.S. National COVID Cohort…